Mohamad Haqiqian

Dr Mohamad Haqiqian is a radiopharmaceutical and radiation safety specialist at University College London Hospitals (UCLH) and Curium Pharmaceuticals, specialising in radiopharmaceutical manufacturing, development, radiation safety, and applied medical physics. He holds a PhD, MSc, and BSc in Nuclear Engineering and Medical Radiation Engineering. His research includes in vivo and in vitro studies investigating combination therapies integrating nanotechnology and radiation therapy for pancreatic cancer. He has extensive experience in GMP-compliant radiopharmaceutical manufacturing, quality assurance, radiation physics, dosimetry, and regulatory compliance. He actively contributes to radiation safety training, supporting innovation and operational excellence in nuclear medicine and targeted radiopharmaceuticals